Next, we explored available tumor sequencing data from large cohorts that closely match the tumor type and subtype described in our patient cases with the aim of further clarifying the biological relevance of ATM loss-of-function variants in the carcinogenesis of gallbladder, uterus, duodenum, kidney, lung, and sarcomas. The gene discussed is ATM; the disease is sarcoma.